
New NeuraBlend™ Calming Chew is a melatonin-free daily soft chew that combines 10 active ingredients, including valerian root, ashwagandha, L-theanine, and a postbiotic blend, to help support calm behavior.
NEW YORK, Oct. 13, 2026 /PRNewswire/ -- PetLabCo.®, a leading pet wellness brand creating science-backed, breakthrough solutions to help pets live healthier, happier lives, today announced the launch of NeuraBlend™ Calming Chew, a daily soft calming dog chew to support emotional balance and help dogs navigate stress and changes in routine.
NeuraBlend™ Calming Chew is PetLabCo.®'s first calming product. The melatonin-free dog calming soft chews can be incorporated into a dog's daily wellness routine and can be used to help during stressful situations, such as travel, fireworks or changes in routine. Each soft, pork-flavored chew features 10 calming active ingredients that work across four pathways, including gut-brain, stress response, neurotransmitter and botanical support.
A few key highlights of this vet-reviewed formulation include:
- PRIOME® MW, a postbiotic blend designed to support the gut-brain axis
- KSM-66® Ashwagandha Root Extract, a clinically studied, branded adaptogen ingredient
- No melatonin, making it suitable for daily use without leaving dogs sluggish
"Supporting a dog through everyday stressors starts with understanding that emotional well-being is connected to multiple systems in the body," said Dr. Israel Swann, DVM, PetLabCo.® consultant. "A dog calming supplement can support dogs through everyday stress and help pet parents establish a consistent routine ahead of anticipated events like travel, boarding, or unfamiliar environments."
Launching ahead of the holiday season, PetLabCo.®'s NeuraBlend™ Calming Chew offers pet parents a simple way to incorporate calming support into their dogs' daily routines. The soft chews can be administered in preparation of road trips, flights, boarding stays, houseguests, fireworks and other disruptions to help dogs maintain a normal, relaxed disposition.
"While holiday travel can be exciting for families, changes in routine can be tricky for dogs," said Chris Masanto, CEO and Co-Founder of PetLabCo.® "We wanted to create a dog calming chew that could fit naturally into a dog's daily routine while also giving pet parents an easy way to prepare for moments they know may be stressful."
NeuraBlend is designed for daily use based on a dog's size, with a specific double-administration protocol leading up to anticipated stressful events (started 7 days ahead, held through the event plus 2 days after).
NeuraBlend joins PetLabCo.®'s portfolio of health and wellness solutions spanning gut health, joint health, seasonal allergy and immune support, and dental care. The launch expands the company's R&D-driven approach into the Calming & Behavior category.
PetLabCo.® NeuraBlend™ Calming Chew is available in a 30-day tub at RRP: $38.60 (S) / $41.26 (M) / $43.93 (L) and can be purchased at https://thepetlabco.com/products/neurablend-calming-chew-for-dogs.
For more information, visit: https://thepetlabco.com/
About PetLabCo.®
PetLabCo.® is on a mission to deliver breakthrough pet health. Everything we do starts with a simple belief: our four-legged family members deserve the very best care we can give them. Every day, we're working toward our vision of being the world's most trusted pet health partner by helping dogs live healthier, happier lives alongside the people who love them most. That means developing innovative, clinically tested health solutions rooted in science, empowering pet parents with trusted education, and being there for the pet community every step of the way. Together our team of industry veterans, PhD Nutritionists, Product Experts, Clinical Scientists, and Specialized Veterinarians take an inquisitive and ambitious approach to R&D in the nutraceutical space that is grounded in (1) scientific evidence and testing and (2) creating new-to-science, proprietary active-ingredient blends that directly address the root causes of specific pet health issues.
SOURCE PetLabCo.
Share this article